therapeutic role of repititive transcranial magnetic stimulation in patients with Fibromyalgia
- Conditions
- Health Condition 1: M797- Fibromyalgia
- Registration Number
- CTRI/2023/04/051395
- Lead Sponsor
- Department of Neurology MLB Medical College, Jhansi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
The study will be conducted on patients attending at the department of neurology and psychiatry , MLB MC, Jhansi India and diagnosed as fibromyalgia as per ACR guideline 2010.
FMS patients will be excluded from the study, if they had following conditions: i) unable to give written informed consent form ii) History of seizures iii) History of seizures in first-degree relatives iv) History of any illness involving the brain v) Consumption of medications (like tramadol, acetylcholinesterase inhibitors, anticholinergics, antiemetics,antihistamines, baclofen, Ã?-blockers, cephalosporins,cyclosporine etc) known to lower the seizure threshold vi) History of tinnitus vii) History of bipolar disorder viii) having implants of defibrillators or neurostimulators or cardiac pacemakers ix) pregnant or lactating x) having chronic systemic disease, inflammatory joint diseases, secondary FM, history of trauma xi) with a concomitant diagnosis of chronic fatigue syndrome and/or any psychiatric disorder xii) currently undergoing psychotherapy.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome will be defined as a reduction in pain intensity. This will be assessed with the help of Numerical Pain Rating Scale (NPRS), an 11-point numerical scale ranging from â??0â?? representing â??No painâ?? to â??10â?? representing â??Pain as bad as you can imagineâ?? or â??Worst pain imaginableâ??Timepoint: at the end of the intervention then at 1 month and 3 month of end of interention
- Secondary Outcome Measures
Name Time Method Pain related depression, anxiety, impact of pain and quality of life, as secondary outcomes will be assessed using FIQR ; Hamilton Depression Rating Scale (HDRS); Hamilton Anxiety Rating Scale (HARS) questionnaire .Timepoint: at the end of the intervention then at 1 month and 3 month of end of interention